Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_1
3
30%
Ph phase_4
6
60%

Phase Distribution

3

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 4Post-market surveillance
6(60.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(8)
Other(1)

Detailed Status

Completed8
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (30.0%)
Phase 46 (60.0%)
N/A1 (10.0%)

Trials by Status

unknown110%
completed880%
not_yet_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10